Directorate Change

JPMorgan Indian Invest Trust PLC
13 February 2024
 

       JPMORGAN INDIAN INVESTMENT TRUST PLC

( the "Company")

 

DIRECTORATE AND BOARD COMMITTEE CHANGES

 

Legal Entity Identifier: 549300OHW8R1C2WBYK02

 

As previously announced in the Company's 2023 Annual Report and Financial Statements, and following the Annual General Meeting of the Company, which was held today, the Company confirms that Rosemary Morgan  has retired from the Board to be  replaced by  Jeremy Whitley  as Chairman with effect from 13th February 2024. Vanessa Donegan has assumed the role of Senior Independent Director following Jeremy's appointment as Charman.

 

The Board would like to thank Rosemary Morgan  for her wise counsel and valuable contribution to the Company during her tenure.

 

 

The composition of all the Board committees is as follows:

 

Director


Audit &Risk Committee

Management Engagement Committee

 

Nomination Committee

Remuneration Committee

Jeremy Whitley*


Attends by invitation

Chairman

Member

Member

Vanessa Donegan**


Member

Member

Chairman

Chairman

Jasper Judd


Chairman

Member

Member

Member

Khozem Merchant 


Member

Member

Member

Member

 

 

*Board Chairman

**Senior Independent Director

 

13th February 2024

 

For further information, please contact:

 

 

Divya Amin

For and on behalf of

JPMorgan Funds Limited, Company Secretary

Telephone 0800 20 40 20 (or +44 1268 44 44 70 )

 


 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100